A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer-Reference-Cited by-同舟云学术

A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer

Published:2007-10 Issue:9 Volume:18 Page:1093-1101
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Cree Ian A.,Kurbacher Christian M.,Lamont Alan,Hindley Andrew C.,Love Sharon

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference33 articles.

1. How should we manage patients with ‘platinum-sensitive’ recurrent ovarian cancer?;Ledermann;Cancer Invest,2004

2. Emerging role of topotecan in front-line treatment of carcinoma of the ovary;Coleman;Oncologist,2002

3. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J Clin Oncol,2001

4. Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study;Omura;J Clin Oncol,2003

5. Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: a randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group;Piccart;J Clin Oncol,2000

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids;Small Methods;2023-10-26

2. Epithelial ovarian cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023

3. Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs;Human Cell;2022-12-07

4. Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome;International Journal of Oncology;2022-09-08

5. BIOMARKERS, TYPES AND ROLE IN PERSONALIZED MEDICINE;Russian Journal for Personalized Medicine;2022-07-12